Skip Navigation

Faculty Directory

E. Wangeci Kagucia, PhD

  • Assistant Scientist

Departmental Affiliations

Center & Institute Affiliations

Contact Information

415 N. Washington Street
Baltimore, Maryland 21231

443-272-1290

View Current Courses

Education

PhD, Johns Hopkins Bloomberg School of Public Health, 2018
MHS, Johns Hopkins Bloomberg School of Public Health, 2007
BA, Wellesley College, 2005

  • Vaccine schedule optimization
  • mHealth
  • Vaccine impact
  • Vaccination reminders
  • Vaccination incentives
  • Vaccine epidemiology

Selected publications

  • Gibson DG, Ochieng B, Kagucia EW, et al. Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial. Lancet Glob Heal. 2017;5(4):e428-e438.
  • Barger-Kamate B, Deloria Knoll M, Kagucia EW, et al. Pertussis-Associated Pneumonia in Infants and Children From Low- and Middle-Income Countries Participating in the PERCH Study. Clin Infect Dis 2016;63(suppl 4):S187-S196. doi:10.1093/cid/ciw546
  • Gibson DG, Ochieng B, Kagucia EW, Obor D, Odhiambo F, O'Brien KL, Feikin DR. Individual level determinants for not receiving immunization, receiving immunization with delay, and being severely underimmunized among rural western Kenyan children. Vaccine. 2015 Nov 27;33(48):6778-85
  • Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, et al. (2013) Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites. PLoS Med 10(9): e1001517.
  • Durbin AP, Wright PF, Cox A, Kagucia W, Elwood D, Henderson S, Wanionek K, Speicher J, Whitehead SS, Pletnev AG. The live attenuated chimeric vaccine rWN/DEN4?30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers. Vaccine. 2013 Nov 19;31(48):5772-7. Epub 2013 Aug 19